462 related articles for article (PubMed ID: 30376881)
41. Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes.
Sintini I; Graff-Radford J; Senjem ML; Schwarz CG; Machulda MM; Martin PR; Jones DT; Boeve BF; Knopman DS; Kantarci K; Petersen RC; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
Brain; 2020 Jul; 143(7):2281-2294. PubMed ID: 32572464
[TBL] [Abstract][Full Text] [Related]
42. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
[TBL] [Abstract][Full Text] [Related]
43. Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers.
Koychev I; Hofer M; Friedman N
J Nucl Med; 2020 Oct; 61(10):1413-1418. PubMed ID: 32764121
[TBL] [Abstract][Full Text] [Related]
44. Pathology steered stratification network for subtype identification in Alzheimer's disease.
Xu E; Zhang J; Li J; Song Q; Yang D; Wu G; Chen M
Med Phys; 2024 Feb; 51(2):1190-1202. PubMed ID: 37522278
[TBL] [Abstract][Full Text] [Related]
45. MRI in the new era of antiamyloid mAbs for the treatment of Alzheimer's disease.
Filippi M; Cecchetti G; Agosta F
Curr Opin Neurol; 2023 Aug; 36(4):239-244. PubMed ID: 37382144
[TBL] [Abstract][Full Text] [Related]
46. In vivo tau PET imaging in dementia: Pathophysiology, radiotracer quantification, and a systematic review of clinical findings.
Hall B; Mak E; Cervenka S; Aigbirhio FI; Rowe JB; O'Brien JT
Ageing Res Rev; 2017 Jul; 36():50-63. PubMed ID: 28315409
[TBL] [Abstract][Full Text] [Related]
47. Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease.
Lowe VJ; Lundt ES; Albertson SM; Przybelski SA; Senjem ML; Parisi JE; Kantarci K; Boeve B; Jones DT; Knopman D; Jack CR; Dickson DW; Petersen RC; Murray ME
Alzheimers Dement; 2019 Jul; 15(7):927-939. PubMed ID: 31175025
[TBL] [Abstract][Full Text] [Related]
48. A literature review of MRI techniques used to detect amyloid-beta plaques in Alzheimer's disease patients.
Yu B; Shan Y; Ding J
Ann Palliat Med; 2021 Sep; 10(9):10062-10074. PubMed ID: 34551578
[TBL] [Abstract][Full Text] [Related]
49. Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities.
Parent MJ; Zimmer ER; Shin M; Kang MS; Fonov VS; Mathieu A; Aliaga A; Kostikov A; Do Carmo S; Dea D; Poirier J; Soucy JP; Gauthier S; Cuello AC; Rosa-Neto P
J Neurosci; 2017 Dec; 37(50):12263-12271. PubMed ID: 29097597
[TBL] [Abstract][Full Text] [Related]
50. Change in Cerebrospinal Fluid Tau Microtubule Binding Region Detects Symptom Onset, Cognitive Decline, Tangles, and Atrophy in Dominantly Inherited Alzheimer's Disease.
Horie K; Li Y; Barthélemy NR; Gordon B; Hassenstab J; Benzinger TLS; Fagan AM; Morris JC; Karch CM; Xiong C; Allegri R; Mendez PC; Ikeuchi T; Kasuga K; Noble J; Farlow M; Chhatwal J; Day G; Schofield PR; Masters CL; Levin J; Jucker M; Lee JH; Roh JH; Sato C; Sachdev P; Koyama A; Reyderman L; Bateman RJ; McDade E;
Ann Neurol; 2023 Jun; 93(6):1158-1172. PubMed ID: 36843330
[TBL] [Abstract][Full Text] [Related]
51. A focus on structural brain imaging in the Alzheimer's disease neuroimaging initiative.
Braskie MN; Thompson PM
Biol Psychiatry; 2014 Apr; 75(7):527-33. PubMed ID: 24367935
[TBL] [Abstract][Full Text] [Related]
52. Feasibility and acceptance of simultaneous amyloid PET/MRI.
Schütz L; Lobsien D; Fritzsch D; Tiepolt S; Werner P; Schroeter ML; Berrouschot J; Saur D; Hesse S; Jochimsen T; Rullmann M; Sattler B; Patt M; Gertz HJ; Villringer A; Claßen J; Hoffmann KT; Sabri O; Barthel H
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2236-2243. PubMed ID: 27435367
[TBL] [Abstract][Full Text] [Related]
53. Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum.
Allison SL; Koscik RL; Cary RP; Jonaitis EM; Rowley HA; Chin NA; Zetterberg H; Blennow K; Carlsson CM; Asthana S; Bendlin BB; Johnson SC
Neuroimage Clin; 2019; 23():101895. PubMed ID: 31252287
[TBL] [Abstract][Full Text] [Related]
54. Recent Advances in Imaging of Preclinical, Sporadic, and Autosomal Dominant Alzheimer's Disease.
Buckley RF
Neurotherapeutics; 2021 Apr; 18(2):709-727. PubMed ID: 33782864
[TBL] [Abstract][Full Text] [Related]
55. Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer's disease.
Ortner M; Drost R; Hedderich D; Goldhardt O; Müller-Sarnowski F; Diehl-Schmid J; Förstl H; Yakushev I; Grimmer T
BMC Neurol; 2019 Oct; 19(1):264. PubMed ID: 31672138
[TBL] [Abstract][Full Text] [Related]
56. PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI).
Rafii MS; Lukic AS; Andrews RD; Brewer J; Rissman RA; Strother SC; Wernick MN; Pennington C; Mobley WC; Ness S; Matthews DC;
J Alzheimers Dis; 2017; 60(2):439-450. PubMed ID: 28946567
[TBL] [Abstract][Full Text] [Related]
57. Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease.
Dean DC; Hurley SA; Kecskemeti SR; O'Grady JP; Canda C; Davenport-Sis NJ; Carlsson CM; Zetterberg H; Blennow K; Asthana S; Sager MA; Johnson SC; Alexander AL; Bendlin BB
JAMA Neurol; 2017 Jan; 74(1):41-49. PubMed ID: 27842175
[TBL] [Abstract][Full Text] [Related]
58. Functional neuroimaging findings in healthy middle-aged adults at risk of Alzheimer's disease.
Habib M; Mak E; Gabel S; Su L; Williams G; Waldman A; Wells K; Ritchie K; Ritchie C; O'Brien JT
Ageing Res Rev; 2017 Jul; 36():88-104. PubMed ID: 28342882
[TBL] [Abstract][Full Text] [Related]
59. Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia.
Lowe VJ; Wiste HJ; Senjem ML; Weigand SD; Therneau TM; Boeve BF; Josephs KA; Fang P; Pandey MK; Murray ME; Kantarci K; Jones DT; Vemuri P; Graff-Radford J; Schwarz CG; Machulda MM; Mielke MM; Roberts RO; Knopman DS; Petersen RC; Jack CR
Brain; 2018 Jan; 141(1):271-287. PubMed ID: 29228201
[TBL] [Abstract][Full Text] [Related]
60. Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting.
Weise D; Tiepolt S; Awissus C; Hoffmann KT; Lobsien D; Kaiser T; Barthel H; Sabri O; Gertz HJ
J Alzheimers Dis; 2015; 48(2):425-32. PubMed ID: 26402006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
